Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin

by Elena A. Blokhina, Eugenia S. Mardanova, Liudmila A. Stepanova, Liudmila M. Tsybalova, Nikolai V. Ravin
Published 2020-01-01

Highly Immunogenic Nanoparticles Based on a Fusion Protein Comprising the M2e of Influenza A Virus and a Lipopeptide

by Anna A. Zykova, Elena A. Blokhina, Roman Y. Kotlyarov, Liudmila A. Stepanova, Liudmila M. Tsybalova, Victor V. Kuprianov, Nikolai V. Ravin
Published 2020-10-01

Abstract P-36: HBc4M2e Virus-Like Particles for Influenza A Vaccine Development: a Cryo-EM Study

by Alexey V. Shvetsov, Evgeny B. Pichkur, Tatiana A. Shtam, Vladimir V. Egorov, Liudmila M. Tsybalova, Liudmila A. Stepanova, Aram A. Shaldzhyan, Yana A. Zabrodskaya
Published 2019-06-01

Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.

by Liudmila M Tsybalova, Liudmila A Stepanova, Marina A Shuklina, Eugenia S Mardanova, Roman Y Kotlyarov, Marina V Potapchuk, Sergei A Petrov, Elena A Blokhina, Nikolai V Ravin
Published 2018-01-01

Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes

by Liudmila A. Stepanova, Eugenia S. Mardanova, Marina A. Shuklina, Elena A. Blokhina, Roman Y. Kotlyarov, Marina V. Potapchuk, Anna A. Kovaleva, Inna G. Vidyaeva, Alexandr V. Korotkov, Elizaveta I. Eletskaya, Nikolai V. Ravin, Liudmila M. Tsybalova
Published 2018-04-01

Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

by Liudmila A Stepanova, Roman Y Kotlyarov, Anna A Kovaleva, Marina V Potapchuk, Alexandr V Korotkov, Mariia V Sergeeva, Marina A Kasianenko, Victor V Kuprianov, Nikolai V Ravin, Liudmila M Tsybalova, Konstantin G Skryabin, Oleg I Kiselev
Published 2015-01-01